133 related articles for article (PubMed ID: 6322421)
1. Isolation and characterization of a Mo-MuSV-transformed TB cell line that produces noninfectious MuSV particles with uncleaved gag protein which is processed in the presence of Mo-MuLV.
Soong MM; Yuen PH; Wong PK
Virology; 1984 Jan; 132(2):390-400. PubMed ID: 6322421
[TBL] [Abstract][Full Text] [Related]
2. Restriction of Moloney murine leukemia virus replication in Moloney murine sarcoma virus-infected cells.
Yuen PH; Soong MM; Kissil MS; Wong PK
Virology; 1984 Jan; 132(2):377-89. PubMed ID: 6322420
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of the in vitro products generated by proteolytic cleavage of Gazdar murine sarcoma virus p65gag.
Maxwell SA; Arlinghaus RB
J Gen Virol; 1985 Jan; 66 ( Pt 1)():97-107. PubMed ID: 2981963
[TBL] [Abstract][Full Text] [Related]
4. Characterization of viral polyproteins in cells transformed and producing Moloney murine sarcoma virus-124.
Wood TG; Lyons DD; Ng VL; Murphy EC; Arlinghaus RB
Biochim Biophys Acta; 1980 Jul; 608(2):215-31. PubMed ID: 6156703
[TBL] [Abstract][Full Text] [Related]
5. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products.
Henderson LE; Sowder R; Copeland TD; Smythers G; Oroszlan S
J Virol; 1984 Nov; 52(2):492-500. PubMed ID: 6333515
[TBL] [Abstract][Full Text] [Related]
6. Murine retrovirus Pr65gag forms a 130K dimer in the absence of disulfide reducing agents.
Yoshinaka Y; Katoh I; Luftig RB
Virology; 1984 Jul; 136(2):274-81. PubMed ID: 6087546
[TBL] [Abstract][Full Text] [Related]
7. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.
Yoshinaka Y; Luftig RB
Virology; 1982 Apr; 118(2):380-8. PubMed ID: 6178211
[No Abstract] [Full Text] [Related]
8. Binding of retrovirus-associated protein kinase and proteins to Staphylococcus aureus.
Kloetzer WS; Arlinghaus RB
J Gen Virol; 1982 Jun; 60(Pt 2):365-70. PubMed ID: 6955449
[TBL] [Abstract][Full Text] [Related]
9. Gag-mos Polyproteins encoded by variants of the Moloney strain of mouse sarcoma virus.
Stanker LH; Horn JP; Gallick GE; Kloetzer WS; Murphy EC; Blair DG; Arlinghaus RB
Virology; 1983 Apr; 126(1):336-47. PubMed ID: 6302990
[TBL] [Abstract][Full Text] [Related]
10. P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity.
Kloetzer WS; Maxwell SA; Arlinghaus RB
Proc Natl Acad Sci U S A; 1983 Jan; 80(2):412-6. PubMed ID: 6601272
[TBL] [Abstract][Full Text] [Related]
11. Virus production by Abelson murine leukemia virus-transformed lymphoid cells.
Shields A; Rosenberg N; Baltimore D
J Virol; 1979 Aug; 31(2):557-67. PubMed ID: 90175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.
Ikuta K; Luftig RB
Virology; 1986 Oct; 154(1):195-206. PubMed ID: 3489314
[TBL] [Abstract][Full Text] [Related]
13. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
Papkoff J; Verma IM; Hunter T
Cell; 1982 Jun; 29(2):417-26. PubMed ID: 6288258
[TBL] [Abstract][Full Text] [Related]
14. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.
Witte ON; Rosenberg N; Paskind M; Shields A; Baltimore D
Proc Natl Acad Sci U S A; 1978 May; 75(5):2488-92. PubMed ID: 209468
[TBL] [Abstract][Full Text] [Related]
15. Biological and molecular biological characterization of the virus progeny from transformed clones MuSV-124 and MuSV-349: evidence for MuLV-specific nucleotide sequences in the MoMuSV size class of RNA from MoMuSV-124.
Dekaban GA; Ball JK; Loosmore SM; McCarter JA
J Gen Virol; 1980 Apr; 47(2):407-22. PubMed ID: 6245178
[TBL] [Abstract][Full Text] [Related]
16. Replication-defective Friend murine leukemia virus particles containing uncleaved gag polyproteins and decreased levels of envelope glycoprotein.
Collins JK; Chesebro B
J Virol; 1981 Jan; 37(1):161-70. PubMed ID: 6163868
[TBL] [Abstract][Full Text] [Related]
17. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.
Wang MQ; Goff SP
J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
Fan H; Chute H; Chao E; Feuerman M
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5965-9. PubMed ID: 6310608
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.
Stocking C; Kollek R; Bergholz U; Ostertag W
Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984
[TBL] [Abstract][Full Text] [Related]
20. In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30.
Yoshinaka Y; Shames RB; Luftig RB; Smythers GW; Oroszlan S
J Gen Virol; 1985 Feb; 66 ( Pt 2)():379-83. PubMed ID: 2578553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
